FATE
Fate Therapeutics, Inc. · Healthcare
CFO Edward J Dulac III sold $86K of Fate Therapeutics, Inc.
Sold$85,757
$48.45Price
1,770Shares
−2%Stake
What FATE did after the filing
- The stock from Thu, Jan 13 close, $42.20
- −18.1%
- S&P 500, same days
- −6.0%
Measured over 30 trading days, to the Feb 28 close.
Traded Tue, Jan 11. Filed Thu, Jan 13, 11:06 AM ET, during the session. Returns use the Jan 13 close and the Feb 28 close. Not investment advice.